Assessment of subclinical myocardial dysfunction and osteogenic biomarkers in normoglycemic individuals with familial predisposition to type 2 diabetes mellitus.
Eğlenoğlu G, Uge M, et al. • Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association • 2026
Normoglycemic first-degree relatives of type 2 diabetes mellitus patients exhibit early myocardial impairment detectable by LV-STE and reduced osteocalcin levels, suggesting subclinical cardiometabolic dysfunction before overt disease onset.
Key Findings
Results
Normoglycemic first-degree relatives of type 2 diabetes mellitus patients showed significantly lower left ventricular strain values across all assessed views compared to controls.
Strain parameters assessed included short-axis basal, mid, and apical views as well as apical four-chamber (A4C), two-chamber (A2C), and three-chamber (A3C) views
Left Ventricular Speckle-tracking echocardiography (LV-STE) was used to assess global longitudinal and circumferential strain
All participants were normoglycemic, indicating subclinical dysfunction prior to overt disease
The study group comprised 80 individuals with at least one first-degree relative diagnosed with type 2 diabetes mellitus, compared to 80 controls without such family history
Results
Serum osteocalcin levels were significantly lower in normoglycemic first-degree relatives of type 2 diabetes mellitus patients compared to controls.
Osteocalcin levels were measured by ELISA
Osteocalcin was weakly negatively correlated with fasting plasma glucose level
Osteoprotegerin and osteopontin were also measured but did not show the same pattern of significant reduction
No significant associations were found between osteocalcin levels and myocardial strain parameters
Results
Osteoprotegerin was positively correlated with LDL cholesterol in the study population.
Osteoprotegerin levels were measured by ELISA in all 160 participants
The correlation was identified between serum osteoprotegerin and LDL-C levels
No significant associations were found between osteoprotegerin and myocardial strain parameters
This finding suggests a potential link between osteoprotegerin and lipid-related cardiometabolic risk
Results
No significant associations were found between myocardial strain parameters and osteogenic biomarkers in normoglycemic first-degree relatives of type 2 diabetes mellitus patients.
Biomarkers assessed included osteocalcin, osteopontin, and osteoprotegerin
Strain parameters assessed included global longitudinal and circumferential strain from multiple views
Despite both strain impairment and osteocalcin reduction being independently observed, they did not correlate with each other
This suggests that subclinical myocardial dysfunction and altered osteogenic biomarker profiles may represent parallel but independent early abnormalities
Methods
The study enrolled 160 normoglycemic participants to evaluate subclinical myocardial and metabolic abnormalities in individuals with familial predisposition to type 2 diabetes mellitus.
80 individuals had at least one first-degree relative diagnosed with type 2 diabetes mellitus (study group)
80 individuals without a family history of type 2 diabetes mellitus served as controls
All participants were normoglycemic at the time of enrollment
Serum osteocalcin, osteopontin, and osteoprotegerin levels were measured by ELISA, and LV-STE was performed in all participants
Eğlenoğlu G, Uge M, Çulcuoğlu &, Esen &, Üzüm Y, Pamuk B, et al.. (2026). Assessment of subclinical myocardial dysfunction and osteogenic biomarkers in normoglycemic individuals with familial predisposition to type 2 diabetes mellitus.. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. https://doi.org/10.1055/a-2790-9134